Voyageur Pharmaceuticals Ltd. (VYYRF)
OTCMKTS · Delayed Price · Currency is USD
0.1243
0.00 (0.00%)
Sep 10, 2025, 8:00 PM EDT
Voyageur Pharmaceuticals Market Cap
Voyageur Pharmaceuticals has a market cap or net worth of $20.63 million as of September 12, 2025. Its market cap has increased by 271.08% in one year.
Market Cap
20.63M
Enterprise Value
20.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since March 10, 2017, Voyageur Pharmaceuticals's market cap has increased from 3.53M to 20.63M, an increase of 483.94%. That is a compound annual growth rate of 23.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 20.63M | 125.73% |
| Dec 31, 2024 | 9.14M | 21.27% |
| Dec 29, 2023 | 7.54M | 1.58% |
| Dec 30, 2022 | 7.42M | 2.46% |
| Dec 31, 2021 | 7.24M | 58.26% |
| Dec 31, 2020 | 4.58M | 9.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 375.53M |
| American Oncology Network | 353.52M |